Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Synuca Therapeutics ApS
APS
Active
CVR 45367282
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
2 ansatte
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Synuca Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
LR
Lasse Reimer
Management
Management
2025
WB
William Brown
Management
Management
2025
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (2)
AG
Anker Gunvald Lundemose
Chairman
Chairman
2026
CE
Claus Elsborg Olesen
Board of Directors
Board of Directors
2026
Aktionærer
Pr. seneste årsrapport
80–100%
Shareholder
Type
Ownership
Votes
Since
CLAUS OLESEN HOLDING ApS
Company
25–33.32%
25–33.32%
2025
BODD ApS
Company
25–33.32%
25–33.32%
2025
Raul Holding ApS
Company
15–19.99%
15–19.99%
2026
PHJ 2025 Holding ApS
Company
15–19.99%
15–19.99%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Synuca Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
